Synopsis
Synopsis
0
EU WC
0
KDMF
0
VMF
0
Listed Dossiers
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Acetate, Goserelin
2. Goserelin
3. Ici 118630
4. Ici-118630
5. Ici118630
6. Zoladex
1. 145781-92-6
2. Fertilan
3. Zoladex
4. Goserelin (acetate)
5. Goserelin Acetate [jan]
6. 6yuu2pv0u8
7. Dsstox_cid_26736
8. Dsstox_rid_81865
9. Dsstox_gsid_46736
10. 1-9-luteinizing Hormone-releasing Factor (swine), 6-(o-(1,1-dimethylethyl)-d-serine)-, 2-(aminocarbonyl)hydrazide, Acetate (salt)
11. Cas-145781-92-6
12. Ici-118630 Acetate
13. Unii-6yuu2pv0u8
14. Novgos
15. Zoladex La
16. Zoladex (tn)
17. Ncgc00167588-02
18. Ncgc00183275-01
19. Schembl6094
20. Goserelin Acetate (jan/usp)
21. Chembl1200501
22. Dtxsid9046736
23. Goserelin Acetate [vandf]
24. Goserelin Acetate [mart.]
25. Glxc-26187
26. Goserelin Acetate [usp-rs]
27. Goserelin Acetate [who-dd]
28. Tox21_112579
29. Tox21_112937
30. Bdbm50247974
31. Hy-13673a
32. Ici118630
33. Mfcd01747329
34. Cs-4509
35. Goserelin Acetate [orange Book]
36. (d-ser(tbu)6,azagly10)-lhrh Acetate
37. Goserelin Acetate [usp Monograph]
38. D00573
39. 781g926
40. Goserelin Acetate, >=99% (hplc), White Powder
41. Q27265738
42. Goserelin, European Pharmacopoeia (ep) Reference Standard
43. H-pyr-his-trp-ser-tyr-d-ser(tbu)-leu-arg-pro-nhnhconh2 Acoh
44. Goserelin Acetate, United States Pharmacopeia (usp) Reference Standard
45. Goserelin For Nmr Identification, European Pharmacopoeia (ep) Reference Standard
46. 6-[o-(1,1-dimethylethyl)-d-serine]-1-9-luteinizing Hormone-releasing Factor (swine) 2-(aminocarbonyl)hydrazide Acetate (salt)
Molecular Weight | 1329.5 g/mol |
---|---|
Molecular Formula | C61H88N18O16 |
Hydrogen Bond Donor Count | 18 |
Hydrogen Bond Acceptor Count | 18 |
Rotatable Bond Count | 32 |
Exact Mass | 1328.66256879 g/mol |
Monoisotopic Mass | 1328.66256879 g/mol |
Topological Polar Surface Area | 533 Ų |
Heavy Atom Count | 95 |
Formal Charge | 0 |
Complexity | 2590 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antineoplastic Agents, Hormonal
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
About the Company : With more than 50 years of experience and expertise, Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology comp...
About the Company : Aspen API is the cooperative entity formed by Aspen Oss in the Netherlands and Fine Chemicals Corporation in South Africa. With quality, compliance, and teamwork at its core, Aspen...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
About the Company : Omgene Life Sciences Private Limited is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically